Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health have identified a strong association between the product of a gene expressed in most cancers, including the most common type of head and neck cancer, and elevated levels of white blood cells that produce antibodies within tumors.
A University of Texas at Arlington bioengineering professor is leading a state-funded project that will try to identify what T-cells are detecting in cancerous cells to better craft a personalized cancer immunotherapy.
MIT researchers discovered why the immune system mounts such a lackluster response to lung cancer, even after treatment with immunotherapy drugs: Bacteria naturally found in the lungs help create an environment that suppresses T-cell activation in the lymph nodes near the lungs.